Osaka, Japan

Kazuki Hashiba

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Hokkaido University, Nitto-Denko Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuki Hashiba. Retrieved from https://idiyas.com/inventor/kazuki-hashiba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuki Hashiba: Innovator in Lipid Nanoparticle Technology

Introduction

Kazuki Hashiba is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of lipid nanoparticles for gene transfer applications. His innovative work addresses critical challenges in targeted drug delivery systems.

Latest Patents

Kazuki Hashiba holds a patent for lipid nanoparticles designed to function as gene transfer carriers. This invention specifically targets selective transfer to the liver or spleen, enhancing the efficacy of gene therapies. The lipid nanoparticles incorporate a pH-sensitive cationic lipid, which is crucial for their functionality.

Career Highlights

Throughout his career, Kazuki Hashiba has worked with esteemed institutions, including Hokkaido University and Nitto Denko Corporation. His experience in these organizations has allowed him to refine his expertise in nanoparticle technology and its applications in medicine.

Collaborations

Kazuki has collaborated with various professionals in his field, including Yusuke Sato. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Kazuki Hashiba's work in lipid nanoparticle technology represents a significant advancement in gene transfer methods. His innovative approach has the potential to improve therapeutic outcomes in various medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…